Organon & Co. (OGN)
A+
Pipeline Grade
Financial Position (from SEC Filings)
$1,116.0M
Cash & Equivalents
$225.0M
Quarterly Burn Rate
$3,514M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (18 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM
HYZAAR |
APPROVED | — |
|
EZETIMIBE, SIMVASTATIN
VYTORIN |
APPROVED | — |
|
MIRTAZAPINE
REMERON |
APPROVED | — |
|
BETAMETHASONE ACETATE, BETAMETHASONE SODIUM PHOSPHATE
CELESTONE SOLUSPAN |
APPROVED | — |
|
MONTELUKAST SODIUM
SINGULAIR |
APPROVED | — |
|
CARBIDOPA, LEVODOPA
SINEMET |
APPROVED | Acute Rhinosinusitis, Adenoids Hypertrophy, Allergic Rhinitis, Asthma, Asthma, Exercise-Induced, Atherosclerosis, Atopic Dermatitis, Bipolar Disorder, Bipolar I Disorder, Bronchiolitis, Chronic Idiopathic Urticaria, Conjunctivitis, Allergic, Contraception, Controlled Ovarian Stimulation, COPD, Coronary Disease, Coronary Heart Disease, Diabetes Mellitus, Type 2, Dyslipidemia, Fertility Issues, HDL Cholesterol, Hypercholesterolaemia, Hypercholesterolemia, Hyperlipidemia, Hypertension, In Vitro Fertilization, Infertility, Infertility, Female, Infertility,Female, Metabolic Syndrome, Migraine, Migraine Disorders, Nasal Polyps, Neonates, Osteoarthritis, Osteoporosis, Ovarian Function Insufficiency, Pain, Palmoplantar Keratoderma, Perennial Allergic Rhinitis, Plaque Psoriasis, Pregnancy, Primary Hypercholesterolemia, Proteinuria, Psychosis, Recurrent Low Back Pain, Respiratory Syncytial Virus Bronchiolitis, Rhinitis Allergic, Rhinitis, Allergic, Seasonal, Schizophrenia, Seasonal Allergic Rhinitis, Spondylarthropathi |
|
EZETIMIBE
ZETIA |
APPROVED | — |
|
FINASTERIDE
PROSCAR |
APPROVED | — |
|
DESLORATADINE
CLARINEX |
APPROVED | — |
|
RIZATRIPTAN BENZOATE
MAXALT-MLT |
APPROVED | — |
|
ATORVASTATIN CALCIUM, EZETIMIBE
LIPTRUZET |
NDA | — |
|
BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE
LOTRISONE |
NDA | — |
|
SIMVASTATIN
ZOCOR |
NDA | — |
|
DESLORATADINE, PSEUDOEPHEDRINE SULFATE
CLARINEX D 24 HOUR |
NDA | — |
|
ETONOGESTREL
NEXPLANON |
NDA | — |
|
BETAMETHASONE DIPROPIONATE
DIPROLENE |
NDA | — |
|
MOMETASONE FUROATE
ELOCON |
NDA | — |
|
ALENDRONATE SODIUM
FOSAMAX |
NDA | — |
Upcoming Catalysts
No upcoming catalysts detected for this company.